Ronny Drapkin

ORCID: 0000-0002-6912-6977 · 29 papers in corpus
observational 2008
Gynecologic Oncology ·doi:10.1016/j.ygyno.2008.01.012

BACKGROUND: Early serous carcinomas predominate in the fimbria of women with BRCA mutations (BRCA+). An entity in non-neoplastic mucosa sharing several properties of early serous carcinomas--the "p53 signature"--has been described in the di…

review 2008
Histopathology ·doi:10.1111/j.1365-2559.2007.02938.x

Prolongation of ovarian epithelial cancer survival depends on early detection or improved responses to chemotherapy. Gains in either have been modest at best. Understanding the diverse pathogenesis of this disease is critical to early inter…

other 2008
Clinical cancer research : an official journal of the American Association for Cancer Research ·doi:10.1158/1078-0432.ccr-08-1557

Discriminating between benign and malignant disease is a pivotal diagnostic issue in the care of women with pelvic masses. Identification of serum biomakers that can rellably make the distinction would aid in the proper referral for patient…

review 2007
Clinical medicine & research ·doi:10.3121/cmr.2007.702

Ovarian epithelial cancer is diagnosed in approximately 25,000 women yearly in the United States, accounting for approximately 12,500 deaths. Of these tumors, serous cancer is the most lethal, due to its capacity to spread beyond the reprod…